Sezgin, Y. Et Al. 2024. Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience. Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.8 , 904-909.

Sezgin, Y., Karhan, O., Ileri, S., Ebinc, S., Tunc, S., & Urakci, Z., (2024). Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience. Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.8, 904-909.

Sezgin, Yasin Et Al. "Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience," Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.8, 904-909, 2024

Sezgin, Yasin Et Al. "Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience." Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.8, pp.904-909, 2024

Sezgin, Y. Et Al. (2024) . "Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience." Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.8, pp.904-909.

@article{article, author={Yasin Sezgin Et Al. }, title={Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience}, journal={Journal of the College of Physicians and Surgeons Pakistan}, year=2024, pages={904-909} }